Treatment Could Be the Most Effective Solution for Easing Irritable Bowel Syndrome

A new approach that alters behaviors in individuals with irritable bowel syndrome (IBS) could prove to be more effective than traditional treatments. When offered digitally, these methods might also enhance the speed of relief.

IBS is often accompanied by symptoms such as bloating, diarrhea, constipation, and abdominal pain. While the underlying cause is not entirely understood, disruptions in gut-brain signaling are thought to play a pivotal role. Factors such as intestinal infections and certain foods can irritate the gastrointestinal tract, sending distress signals to the brain, while psychological stress can trigger the opposite response. Patients with IBS are advised to explore relaxation techniques.

While dietary recommendations and medications, like laxatives, provide relief for some, others continue to struggle with symptoms. Consequently, researchers are investigating innovative alternatives, including fecal transplants. Behavioral therapy, often seen as a last resort by physicians, may actually offer greater benefits than standard care according to a 2020 review. This approach may surpass regular treatment efficacy.

Among the methods is cognitive behavioral therapy (CBT), which empowers individuals to modify their thoughts and behaviors to better cope with and accept their symptoms, and gut-directed hypnotherapy, which induces a trance-like state prior to signaling symptom improvement.

Following the release of more studies, Alexander Ford and his colleagues at the University of Leeds in the UK, some of whom contributed to earlier reviews, conducted a comprehensive review of 67 randomized controlled trials with over 7,000 participants. These trials compared behavioral interventions lasting 4 to 12 weeks against various control groups that received conventional treatments like dietary guidance and laxatives, or those on a waiting list for intervention.

“This represents the most extensive review of behavioral treatments for irritable bowel syndrome in terms of both the number of studies and participants,” stated Perjohan Lindfors from Karolinska Institutet, Sweden.

The findings indicate that CBT and gut-directed hypnotherapy, whether in-person or via apps and the internet, are more beneficial compared to standard treatments when participants evaluated their symptoms pre- and post-treatment.

Rather than typically being provided solely in-person after standard treatments fail, the results imply that behavioral therapies can be utilized much earlier in the process. Ford remarked, “Digital solutions can help expedite the delivery of these treatments.” He further mentioned that such approaches may allow for broader implementation of behavioral therapies. However, before any updates to guidelines can be made, further trials that directly compare digital therapies with traditional treatments are required, which Ford estimates could take another five years.

Additionally, as most participants were unaware of their assigned groups, a portion of the observed benefits may stem from a placebo effect, according to Lindfors. He proposed that trials involving full treatment versus partial treatment could assist in estimating the effect size, assuming all participants genuinely believed they were receiving effective behavioral therapy.